Yüklüyor......
Medullary Thyroid Cancer in the Era of Tyrosine Kinase Inhibitors: To Treat or Not to Treat—and With Which Drug—Those Are the Questions
CONTEXT: Medullary thyroid cancer (MTC) is a rare form of thyroid cancer comprising approximately 4% of all thyroid cancers. The majority of patients have a relatively good prognosis; however, a subgroup of patients will require systemic therapy. Large phase III randomized trials led to the approval...
Kaydedildi:
| Yayımlandı: | J Clin Endocrinol Metab |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Endocrine Society
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4255127/ https://ncbi.nlm.nih.gov/pubmed/25238206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2811 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|